Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Escalier Biosciences
Escalier Biosciences is developing small molecule therapeutics to treat autoimmune diseases, including psoriasis.
Sector
Subsector
Location
total rounds
total raised
Quintessence Biosciences
Quintessence Biosciences is a biopharmaceutical company developing protein-based therapeutics to fight cancer.
Sector
Subsector
Location
total rounds
total raised
SinoMab Bioscience
SinoMab Bioscience is a biopharmaceutical company that develops and commercializes therapeutics.
Sector
Subsector
Location
total rounds
BioIntervene
BioIntervene is a preclinical-stage biopharmaceutical company that focuses on drug discovery and development.
Sector
Subsector
Keywords
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Structured Alpha
announced date
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 16.07.2020. Their latest investor Genesys Partners. Their latest round Post-IPO Equity
Genesys Partners
Genesys Partners is a venture capital firm specializing in early-stage companies in the digital information technology industry.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Amorchem
AmorChem is a Montreal-based VC fund investing in early-stage life science startups.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
Co-Investors
Investors12
Number of lead investors
Number of investors
Genesys Partners
Genesys Partners is a venture capital firm specializing in early-stage companies in the digital information technology industry.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Amorchem
AmorChem is a Montreal-based VC fund investing in early-stage life science startups.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
BDC Venture Capital
BDC is a Canadian bank that supports entrepreneurs through financing and consulting.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Acquisitions3
Fairhaven Pharmaceuticals acquired by Liminal BioSciences
acquirer
date
type
price
Fairhaven Pharmaceuticals
Fairhaven Pharmaceuticals develops oral therapeutics for severe inflammatory conditions.
Sector
Subsector
Location
Telesta Therapeutics acquired by Liminal BioSciences
acquirer
date
type
Telesta Therapeutics
Telesta Therapeutics is a biopharmaceutical company focused on developing transformative human therapeutics.
Sector
Subsector
Keywords
Location
total rounds
total raised
Pathogen Removal and Diagnostic Technologies acquired by Liminal BioSciences
acquirer
date
type
Pathogen Removal and Diagnostic Technologies
Pathogen Removal and Diagnostic Technologies develops innovative products for detecting and removing pathogens.
Sector
Subsector
Keywords
Location
People
Founders1
Pierre Laurin
Pierre Laurin is a senior executive with 28 years of experience in the pharmaceutical and biotechnology industry. Involved in the development of ProMetic’s platform technology since 1989, Pierre Laurin founded ProMetic Life Sciences Inc. in 1994. As Chairman until March, 2011 and President and CEO of the Corporation since its inception, he took the Corporation public on the Toronto Stock Exchange and has since raised over $450 million through equity and debt financing and multinational funding. Pierre Laurin corporate development achievements include the successful close of some 45 licensing agreements and joint venture agreements with multinationals including two strategic agreements with the American Red Cross. Pierre Laurin prior experience also includes positions with various pharmaceutical companies, including Nordic Laboratories (now Sanofi) where he played a pivotal role in the commercial success of Cardizem in Canada. Pierre Laurin holds a B.Sc. in Pharmacy and a Master degree in Pharmaceutical Sciences from the University of Montreal.
current job
organization founded
Pierre Laurin
Employee Profiles14
Shrinal Digm
Communications and digital strategy manager
Eric Beresford
Director medical affairs - rare diseases
